Neutrophils cast neutrophil extracellular traps (NETs) to ensnare microbial pathogens. Nevertheless, the molecular rheostats that regulate NETosis in response to bacteria are not clearly established. We hypothesized that stress-activated protein kinase or c-Jun N-terminal Kinase (SAPK/JNK) is a molecular switch that turns on NETosis in response to increasing concentrations of lipopolysaccharide (LPS)and Gram-negative bacteria. Here we show that Escherichia coli LPS (0111:B4; 10-25 μg/ml), but not phorbol myristate acetate (PMA), activates JNK in human neutrophils in a dose-dependent manner. JNK inhibitors SP600125 and TCSJNK6o, and a TLR4 inhibitor TAK242 suppress reactive oxygen species production and NETosis in LPS-, but not PMA-treated neutrophils. Diphenyleneiodonium suppresses LPS-induced NETosis, confirming that endotoxin induces NADPH oxidase-dependent NETosis. Immunoblots, Sytox Green assays, and confocal microscopy of cleaved caspase-3 and nuclear morphology show that JNK inhibition does not induce apoptosis in LPS-stimulated neutrophils. JNK inhibition also suppresses NETosis induced by two typical Gram-negative bacteria, E. coli and Pseudomonas aeruginosa. Therefore, we propose that neutrophils use a TLR4-dependent, JNKmediated molecular sensing mechanism to initiate NADPH oxidase-dependent suicidal NETosis in response to increasing concentrations of LPS, and Gram-negative bacteria. The LPS-TLR4-JNK activation axis determines the fate of these cells: to be or not to be NETotic neutrophils.
Inhibition of JNK activation and TLR4 signaling suppress LPS-induced ROS production.
Since both PMA and LPS can induce ROS production, we next examined the effects of JNK inhibition in ROS production. DHR123 is a non-fluorescent dye. Upon binding to intracellular ROS, DHR123 is converted to R123, which emits a green fluorescence signal 24 . SP600125 is a commonly used JNK inhibitor 13, [25] [26] [27] ; hence, we performed the DHR123 assay to determine the amount of ROS production following PMA or LPS treatment, in the presence or absence of 10 μM SP600125. Plate reader assays show that the presence of SP600125 suppresses background ROS production in the media control. SP600125 only slightly suppresses PMA-mediated ROS production ( Fig. 2A-B ). By contrast, the presence of SP600125 strongly suppresses LPS-mediated ROS production ( Fig. 2C ). Images of the neutrophils confirm the strong suppression of ROS production by the JNK inhibitor in LPS-, but not in PMA-, treated cells ( Fig. 2D ). These data show that JNK inhibitor SP600125 suppresses LPS-, but not PMA-mediated ROS production in neutrophils.
Although SP600125 suppresses the activation of all isoforms of JNK, some of its effects occur indirectly via suppressing other kinases 26, 28, 29 . Therefore, to further validate the role of JNK activation in ROS production, we used another JNK inhibitor TCSJNK6o, which shows >1000-fold specificity to JNK over other kinases 30 . When the ROS experiments were repeated in the presence or absence of 10 μM TCSJNK6o, plate reader assays show that the inhibitor significantly suppresses LPS-, but not PMA-, mediated ROS production ( Fig. 2E-G ; Supplementary  Fig. S2A-C ). Both of these JNK inhibitors suppressed LPS-mediated ROS production. Therefore, inhibition of JNK suppresses LPS-, but not PMA-, mediated ROS production in neutrophils.
Neutrophils express TLR4 and appropriate signaling molecules, and LPS exerts its intracellular signaling via TLR4 and MyD88-like adaptor proteins 31, 32 . Therefore, to determine whether the LPS-mediated ROS production is dependent on TLR4 signaling, in ROS assays we used an inhibitor (TAK242) that specifically blocks the interaction between TLR4 and its intracellular adaptor proteins [33] [34] [35] . This inhibitor also significantly suppresses ROS production in neutrophils treated with LPS, but not PMA ( Fig. 2E-G ; Supplementary Fig. S2A-C) . Therefore, both JNK activation and TLR4 signaling are important for LPS-mediated ROS production in neutrophils.
Inhibition of JNK activation and TLR4 signaling suppress LPS-mediated NETosis.
Next, we used the common Sytox Green fluorescence plate reader assay as a proxy to investigate the role of JNK in NETosis. Sytox Green is a cell impermeable dye, and emits green fluorescence upon intercalating with the DNA released during NETosis. These assays show that increasing concentrations of LPS increases NETosis (Fig. 3A) . At 100 ng/ ml, LPS does not induce NETosis. As indicated by the large error bars, induction of NETosis is highly variable at an LPS concentration of 1 μg/ml. In certain experiments, LPS at 1 μg/ml does not induce NETosis, whereas in other experiments, LPS at this concentration induces substantial levels of NETosis. By contrast, 10-25 μg/ The ROS values were calculated by considering the PMA-mediated ROS production as 100% at 40-minute time point (n = 3, *p-value < 0.05; Two-way ANOVA with Bonferroni's multiple comparison post test). (D) Confirmation of generation and inhibition of ROS by confocal imaging. R123 (green) and DNA (blue). Confocal images confirm the inhibition of ROS in LPS activated neutrophils but not in neutrophils activated with PMA, at 60-minute time point (n = 3; scale bar 20 μm). (E-G) Measuring R123-based ROS generation kinetics by plate reader assays show that TLR4-TIRAP/TRAM inhibition with TAK242 significantly reduces the generation of ROS in LPS treated Neutrophils. However, the inhibitor does not suppress ROS generation in neutrophils activated with PMA. The ROS values were calculated by considering the PMA-mediated ROS production as 100%, at 40-minute time point (n = 3, *p-value < 0.05; One-way ANOVA with Tukey's post test compared to negative control). See Supplementary Fig. S2 for relative changes in ROS production. Error bars in all the panels represent SEM. ml of LPS reproducibly induces NETosis, resulting in >2.5 fold DNA release compared to baseline conditions. Therefore, LPS concentration is a key factor that determines whether neutrophils undergo NETosis or not.
Various agonists induce different types of NETosis: Nox-dependent or -independent NETosis 3, 10, 36 . To determine the type of NETosis that LPS induces, we conducted the experiments in the presence or absence of diphenyleneiodonium (DPI), an inhibitor of Nox. Sytox Green assays show that DPI not only inhibits PMA-, but also suppresses LPS (25 μg/ml)-mediated NETosis in a dose-dependent manner ( Fig. 3C ; Supplementary Fig. S3 ). Therefore, the E. coli endotoxin induces suicidal Nox-dependent NETosis.
To determine the role of JNK in NETosis, we conducted the Sytox Green assay in the presence or absence of SP600125. The JNK inhibitor suppresses LPS-mediated NETosis in a dose-dependent manner, whereas the inhibitor does not substantially inhibit PMA-mediated NETosis ( Fig. 4A-C) . JNK inhibitor suppresses the baseline NETosis in media control, while it slightly suppresses PMA-mediated NETosis, at early time points. To confirm NETosis, neutrophils were treated with PMA or LPS (25 μg/ml), in the presence or absence of SP600125, for 4 hours and immunostained for myeloperoxidase (MPO). During NETosis, MPO enters nucleus and is found associated with chromatin. Presence of MPO on extracellular chromatin is considered to represent NET formation 2, 7, 8, 37 . Immunoconfocal microscopy images show that MPO is localized in the cytoplasm, around the nuclei, in negative controls either in the presence or absence of SP600125. By contrast, MPO co-localizes to NETs, which were induced by incubating neutrophils with LPS or PMA. SP600125 does not noticeably inhibit PMA-mediated NET formation. However, LPS does not induce NETosis in the presence of SP600125; the nuclear morphology of these cells remains similar to that of the unstimulated control neutrophils ( Fig. 4D ; Supplementary Fig. S4 ). Therefore, inhibiting JNK activation by SP600125 suppresses NETosis.
We repeated the entire set of experiments with a second JNK inhibitor, TCSJNK6o. This inhibitor also suppresses baseline and LPS (25 μg/ml)-, but not PMA-, mediated NETosis as determined by Sytox Green (Fig. 5A -C) and confocal immunofluorescence microscopy ( Fig. 5D ; Supplementary Fig. S5 ). These data (Figs 4 and 5, Supplementary Figs S4 and S5) show that JNK activation is necessary for the induction of LPS-, but not PMA-mediated NETosis.
To determine the role of TLR4 signaling in LPS-mediated NETosis, we incubated the neutrophils with different concentrations of TLR4 inhibitor TAK242, and induced NETosis with LPS (25 μg/ml) or PMA. Both Sytox Green assays ( Fig. 6A -C) and confocal immunofluorescence microscopy ( Fig. 6D ; Supplementary Fig. S6 ) show that the TLR4 inhibitor suppresses LPS-, but not PMA-, mediated NETosis. These studies show that TLR4 signaling is important for LPS-mediated NETosis. 
JNK inhibition suppresses death in neutrophils treated with LPS.
To determine the effect of JNK inhibition during LPS-mediated activation of neutrophils, we next examined the fate of neutrophils stimulated with LPS (25 μg/ml) or PMA. We performed immunoblot analyses of cleaved caspase-3 in control neutrophils, and in neutrophils incubated with PMA or LPS, in the presence or absence of JNK inhibitor SP600125. The immunoblots show that freshly isolated neutrophils have barely detectable cleaved caspase-3; the neutrophils incubated for 4 hours underwent apoptosis to an extent similar to FasL-treated cells. In repeated experiments, the presence or absence of SP600125 does not make any significant difference in the degree of apoptosis in the control cells. By contrast, neutrophils activated with PMA or LPS do not show a significant degree of caspase-3 activation compared to controls (Fig. 7A, B ).
We also conducted fluorescence microscopy after immunostaining for cleaved caspase-3 (cCasp-3; green) to assess NETosis and apoptosis by nuclear morphology and caspase-3 cleavage in these cells. In the control neutrophils, the presence of JNK inhibitor does not change the nuclear morphology ( Fig. 7C; Supplementary Fig. S7 ). suppresses apoptosis in these cells (Fig. 7D ). We did not observe any other caspase 3-independent death, based on cCasp-3 staining and nuclear morphology. Collectively, this data set ( Fig. 7; Supplemental Fig. S7 ; Sytox Green data in Figs 4-6 that show no increase in cell permeability in the presence of the inhibitor) shows that inhibition 
JNK inhibition suppresses E. coli-and P. aeruginosa-induced NETosis.
To demonstrate additional biological relevance of the JNK involvement in NETosis signaling, we studied the role of JNK in Gram-negative bacteria-induced NETosis. NETosis determined by Sytox Green assays and imaging show that both E. coli and P. aeruginosa induce NETosis. We found that JNK inhibitor SP600125 significantly suppresses NETosis induced by both of these bacteria (Fig. 8A,B) . The degree of JNK-mediated NETosis suppression is higher when the number of bacteria are lower (Fig. 8C,D) . NET images also indicate that JNK inhibitor suppresses bacteria-induced NETosis (Fig. 8E,F) . These findings (Fig. 8) show that JNK also regulates NETosis induced by Gram-negative bacteria.
Discussion
Previous studies have attempted to identify the role of JNK in neutrophil functions 18, 19, 26, [38] [39] [40] . However, the results were not conclusive, and the involvement of this stress-activated protein kinase (JNK/SAPK) in NETosis was not clearly established. In attempts to identify the functions of JNK in NETosis, we found that JNK activation is barely detectable in media control and PMA-treated neutrophils. In some experiments, PMA showed a slight, inconsistent activation of JNK above background, but considering all the biological replicates, the activation is not significantly different than non-activated neutrophil controls. The absence of JNK phosphorylation during the activation of neutrophils by PMA is consistent with our recent transcriptomics studies, which predict that PMA does not activate JNK 12 . By contrast, high levels of JNK activation occurs in response to increasing concentrations of LPS and a substantial level of JNK phosphorylation is detectable at higher LPS concentrations ( Fig. 1 ; Supplementary Fig. S1 ). This LPS-mediated JNK activation is consistent with one previous report, but not with others 13, 38 . These differences could be due to the amount and types of LPS used in different studies. Inflammatory cytokines may also potentiate cells to activate JNK at low concentrations of LPS 15, 38 . Some of these reports also relied on indirect measures of JNK activation, whereas we directly determined JNK activation by Western blots. Based on our direct data, it is clear that LPS induces JNK activation in neutrophils in a dose-dependent fashion.
It has previously been established that both PMA and LPS induce ROS production and NETosis 6, 7, 35, 37, 41, 42 . Interestingly, inhibiting JNK activation leads to suppression of ROS production in LPS-, but not in PMA-treated neutrophils ( Fig. 2; Supplementary Fig. S2 ). SP600125 and TCSJNK6o treatments suppress baseline ROS production in negative control cells, and these inhibitors slightly reduce ROS production in the presence of PMA at initial time points. This slight difference in ROS production is attributable to JNK-mediated baseline ROS production. By contrast, ROS production in LPS-treated cells relies fully on JNK activation. Cells including neutrophils respond to LPS via TLR4 signaling 31, 32, 43 . TAK242 specifically blocks the interaction between TLR4 and its intracellular adaptor proteins TIRAP (Toll/interleukin-1 receptor (TIR) domain-containing adaptor protein; also known as MyD88-adapter-like protein or Mal) and TRAM (TIR-domain-containing adapter-inducing interferon-β (TRIF)-related adaptor molecule [33] [34] [35] . Blocking TLR4 interaction with TIRAP/TRAM with TAK242 suppresses LPS-mediated ROS production ( Fig. 2) . LPS does not utilize MyD88-independent signaling mediated via TRAM 31, 32 , hence the TIRAP branch of the TLR4 signaling pathway must regulate ROS production. Furthermore, TLR4-TIRAP signaling can activate MAPK cascade such as MAPK kinase (MKK) 4 and 7 that subsequently activate JNK 44 . Therefore, E. coli (0111:B4) LPS likely regulates ROS production via TLR4-TIRAP-JNK signaling.
PMA exerts its effect by PKC-mediated activation of Nox, ROS production and subsequent NETosis 9, 45 . Inhibition of ROS generated by Nox (e.g., DPI) leads to the suppression of Nox-dependent NETosis 7, 9, 45 . We report here that DPI blocks LPS-mediated NETosis ( Fig. 3; Supplementary Fig. S3 ). Therefore, JNK activation is an upstream event, and that LPS-mediated TLR4 signaling is responsible for JNK activation, which is important for Nox-dependent ROS production and NETosis. JNK can activate transcription factors and promote transcription to help decondense chromatin because our previous studies show that LPS-mediated NETosis could be suppressed by the transcription initiation inhibitor Actinomycin D 12 . Since transcription is a near terminal event in the NETosis pathway, Actinomycin D will inhibit NETosis regardless of the upstream events. The fact that JNK inhibition blocks Nox-mediated ROS production indicates that JNK also plays an upsteam role in activating Nox during LPS-mediated NETosis.
Low concentrations of LPS increase the lifespan of neutrophils 46 , whereas high concentrations of this Gram-negative bacterial cell wall component induces NETosis 6 . Here we show that inhibition of JNK suppresses LPS-induced, but not PMA-mediated NETosis in a dose-dependent manner (Figs 1-5 ). Inhibition of JNK also reduced the background NETosis in the media control reflecting the relevance of background ROS activation in media control for NETosis (Figs 4 and 5) . The same mechanism may be attributable to the slight decrease in PMA-induced NETosis at early time points, when treated with JNK inhibitors. Moreover, immunohistochemistry confirms that JNK is essential to LPS-induced NETosis. MPO is stored in cytoplasmic azuropilic granules in intact neutrophils, but during NETosis it is found on the chromatin 2, 7, 37 . The majority of nuclei are intact and MPO is found in cytoplasmic granules in control cells, unaffected by inhibition of JNK (Figs 4 and 5) or TLR4 (Fig. 6 ). Similar to the PMA treatment, LPS induces chromatin decondensation and NET release along with MPO. These results confirm NETosis 2, 7, 37 . However, JNK inhibition suppresses LPS-induced NETosis such that the nuclear morphology resembles the media control and the MPO granules are in the cytoplasm. This remarkable finding demonstrates that inhibiting JNK activation suppresses LPS-mediated ROS production and maintains neutrophils similar to live cells even in the presence of NETosis-inducing concentrations (10-25 μg/ml) of LPS.
A recent study indicates that LPS from different bacteria induce NETosis to different degrees, and 8 pg LPS (0111:B4) per neutrophil does not induce NETosis on its own 20 . However, the same amount of LPS (0111:B4) robustly induce Nox-independent NETosis in the presence of platelets 20 . Previous studies also used a similar range of concentrations of LPS (0111:B4; e.g., 0.1-5 μg/ml) and identified that the interaction between LPS and the TLR4 present on platelets effectively induces NETosis 21, 22 . Our studies show that robust and reproducible levels of JNK activation and NETosis are detected in the LPS range of 10-25 μg/ml, which is equivalent to 20-50 pg LPS per neutrophil (100 μl of 10-25 μg/ml LPS for 50,000 neutrophils); thus, the amount of LPS is a key factor for inducing JNK activation, and subsequent Nox-dependent NETosis (Figs 1-6 ; Supplementary Figs 1-6 ).
Biological systems are highly regulated to avoid unnecessary harm to the host. Although platelets are present together with neutrophils in the blood and in the wounds with damaged capillaries, both of these cell types are not present in all infection sites. The induction of vital Nox-independent NETosis due to platelet-neutrophil interactions (LPS:TLR4:platelet:neutrophil) described by others [20] [21] [22] may be relevant to clot formation with no ROS production or intravascular NETosis. Furthermore, high blood concentrations of LPS will induce sepsis and multiorgan failure, which are not consistent with supporting the life of the host 47, 48 . By contrast, neutrophils, but not platelets, have the capacity to migrate into various tissues or sites of infection and inflammation 49, 50 . In these loci, neutrophils need to sense the bacterial load and initiate NETosis only when the bacterial load is high. Indeed, local LPS concentrations can be very high at the site of bacterial infection. Hence, we propose that LPS concentration is a key factor that neutrophils use for directly sensing the bacterial load in these milieus to turn on the suicidal NETosis mode with ROS production.
Since JNK modulates apoptosis 18, 19, 51 , it is pertinent to ask whether JNK inhibition promotes apoptosis during the suppression of LPS-mediated NETosis. In apoptotic cells, caspase-3 is cleaved and DNA is condensed, while in NETotic cells, caspase-3 is not cleaved and DNA is decondensed 52, 53 . Confocal microscopy results indicate that the media control, with and without JNK inhibitor, results in the same amount of cleaved caspase-3 and DNA condensation as does the FasL-positive control ( Fig. 7; Supplementary Fig. 7 ). JNK inhibition significantly inhibited NETosis in LPS-treated cells, and also reduced the rate of apoptosis. Thus, JNK inhibition suppresses death of neutrophils even when the cells were treated with high concentrations of LPS (25 μg/ml). JNK plays a role in pyocyanin or crystal-mediated NETosis-like cell death 54, 55 . However, the molecular mechanisms of pyocyanin and crystal-mediated neutrophil death remain unknown. In this study, we have delineated potential mechanisms, and also studied the involvement of JNK in NETosis induced by increasing MOI of Gram-negative bacteria (Fig. 8) .
Our previous studies also show that increasing MOI of E. coli and P. aeruginosa increases Nox-dependent suicidal NETosis 5 . Similar to LPS-mediated NETosis, JNK inhibition suppresses E. coli-and P. aeruginosa-induced NETosis indicating that Gram-negative bacteria also follow similar pathways for regulating NETosis.
In conclusion, we have identified a crucial new role for JNK in regulating LPS-and Gram-negative bacteria-mediated, Nox-dependent NETosis. JNK is essential for endotoxin concentration-dependent LPS-TLR4-mediated NETosis to regulate ROS production, which is necessary for NETosis. We also show that JNK inhibition does not lead to apoptosis or other forms of death, but delays cell death resulting from LPS treatment. Furthermore, this study identified a fundamental difference between PMA-and LPS-mediated Nox-dependent NETosis. Additionally, we demonstrated that similar to LPS, Gram-negative bacteria also require JNK to induce NETs. These findings now place JNK as an important regulatory MAPK required for directly inducing LPS:TLR4:neutrophil-mediated Nox-dependent suicidal NETosis and regulating neutrophil survival ( Fig. 9 ). Activation of JNK acts as a molecular rheostat that senses LPS concentration and bacterial load to turn on Nox-dependent suicidal NETosis. The LPS-TLR4-JNK activation axis determines the viability and fate of these neutrophils: to be or not to be NETotic neutrophils.
Materials and Methods
Primary Human Neutrophils. The study protocol was approved by the Hospital for Sick Children ethics committee. All methods were performed in accordance with the relevant guidelines and regulations. Neutrophils from healthy male donors were used in the study. Donors with eosinophils, or either too low or too high neutrophil count were excluded from the study. Typically, our isolation procedure yields 1-2 million neutrophils per ml of blood. Blood from donors that fall outside of this range has not been used in the study. We collected peripheral blood from healthy male donors in K2 EDTA blood collection tubes (Becton, Dickinson and Co.) after obtaining informed consent. Neutrophils were isolated from these blood samples using the PolymorphPrep (Axis-Shield) protocol. During neutrophil isolation, red blood cells were lysed with a 0.2% (w/v) NaCl hypotonic solution for 30 seconds followed by adding an equal volume of 1.6% (w/v) NaCl solution with 20 mM HEPES buffer to obtain the isotonic condition. Two more washes of 0.85% (w/v) NaCl with 10 mM HEPES solution was done to eliminate red blood cell debris. Neutrophils were resuspended in RPMI medium (Invitrogen) containing 10 mM HEPES (pH 7.2), and counted and viability checked by trypan blue assay before using them for the experiments. Cell density of purified neutrophils was quantified using a hemocytometer, and the purity of the neutrophils was determined by Cytospin preparations. Neutrophil preparations with >95-98% were used in all the experiments, reported in this study. NETs were induced in cells by the addition of 25 nM PMA, and 25 µg/ml LPS (Escherichia coli 0111:B4). For inhibitory assays, the cells were incubated in different concentrations of JNK inhibitor SP600125 or TCSJNK6o, and TLR4-TIRAP/TRAM blocker TAK242 for 30-60 minutes before inducing NETosis. Each condition had a technical duplicate. Each assay was repeated with different donors to obtain biological replicates (n = 3-5; see specific details in figure legends).
Sytox Green NETosis Assay. For measuring NETosis kinetics, the Sytox Green cell-impermeable DNA dye (Life Technologies) was used at a concentration of 5 µM. The fluorescence of the dye was measured with the POLARstar OMEGA fluorescence microplate reader (BMG Labtech) at 30-minute time intervals for up to 240 minutes after cell activation. To calculate % NETosis in each condition, the green fluorescence at time 0-min was subtracted from the fluorescence at each time point and was then divided by the fluorescence values of cell lysed with 0.5% (v/v) Triton X-100 (representing total DNA). The DNA release in each condition is presented as percentages DNA release of total DNA. We ensured that the spontaneous background activation in these samples is less than 30% (of total DNA, by Sytox green assay) to minimize variability. Assays were not completed if the neutrophils were activated at baseline. Neutrophils from the donors used in this study responded well to PMA, and showed 65-100% of NETosis (of total DNA, by Sytox green assay).
DHR123-based ROS Detection
Assay. Intracellular ROS were measured using the DHR123 dye (Life Technologies). The cells were incubated with 25 μM DHR123 for 10 min. After washing, the DHR123 preloaded cells were seeded into 96-well plate and activated with negative control (only media), PMA and LPS, with and without prior incubation of JNK inhibitors or TLR4 inhibitor. The fluorescence was measured every 10 minutes up to 40 minutes by an Omega fluorescence microplate reader. Plate reader assay was used for quantifying ROS, while for the visualization and qualitative analyses confocal imaging was performed in cells under above mentioned different experimental conditions. Bacterial Culture. Escherichia coli (Y1088) and Pseudomonas aeruginosa (mPA01) were grown overnight in sterile LB-broth, selected from single colonies in LB-agar plates. Prior to neutrophil activation (NETosis induction), bacterial cultures were diluted by a factor of ten and sub-cultured for 3 hours. Actively growing cells were harvested and washed three times in 5 mL of phosphate-buffered saline (PBS, pH 7.4) by centrifugation at 5000 × g for 5 minutes at 4 °C. After the final resuspension, the concentration of the optical density (OD) was determined at 600 nm, and different multiplicity of infection (MOI) were calculated using the colony forming unit (CFU) using a formula established in the lab by empirical methods; [CFU] × 10 8 = (OD 600 ) × 30.88 − 99,607.
Immunoblot Analysis. For the immunoblot analysis, 1 × 10 6 cells in each experimental condition were activated, incubated at 37 °C for indicated time points and then placed on ice after the incubation time. The cells were then centrifuged at 20,000 rcf at 4 °C for 10 min. The supernatant was then discarded and the cell pellets were lysed using the lysis buffer containing 1% (w/v) Triton X-100, 25 mM NaF, 50 mM Tris, 10 mM KCl, 10 µg/ ml Aprotinin, 2 mM PMSF, 1 mM Levanisole, 1 mM NaVO 3 , 0.5 µM EDTA, 25 µM Leupeptin, 25 µM Pepstatin, 1 protease inhibitor cocktail tablets per 5 ml (Roche), and 1 phosphatase inhibitor cocktail tablet per 10 ml (Roche). The samples were then vortexed for 10 seconds followed by three times of sonication using an aquasonic sonicator (VWR, model 50D at the highest power setting), at 8-10 °C, 3-min each). A quarter (represents 4x) volume of 5 × loading dye (125 mM Tris.HCl at pH 6.8, 6% (w/v) SDS, 8% (v/v) β-mercaptoethanol, 18% (v/v) glycerol, 5 mM EDTA, 5 mM EGTA, 10 µg/ml Leupeptin, 10 µg/ml Pepstatin, 10 µg/ml Aprotinin, 10 mM NaF, 5 mM NaVO 3 , and 1 mM Levamisole) was added followed by 10 min of incubation at 95 °C with 350 rcm shaking. The samples were size-fractionated in a 5% stacking and 10% resolving gel at 100 V and transferred on a nitrocellulose membrane for 90 minutes at 400 mA. After transfer, the membranes were blocked with 5% (w/v) milk or BSA (for p-JNK immunoblots) in 0.05% PBST for 1 hour at room temperature. The membranes were incubated in the primary antibody at 4 °C overnight followed by 3 washes with 0.1% PBST for 30 minutes. The antibodies used were: anti-phospho-SAPK/JNK (Thr183/Tyr185) (81E11, Cell Signaling) rabbit mAb at 1:1000; anti-cleaved caspase-3 (Asp175, Cell Signaling) rabbit at 1:1000; anti-JNK1 (2C6, 3808, Cell Signaling) mouse mAb at 1:1000; anti-JNK2 (56G8, 9258, Cell Signaling) rabbit mAb at 1:1000; and anti-GAPDH (FL-335, Santa Cruz) rabbit pAb at 1:2500. The membranes were then incubated in the secondary antibody solution for 1 hour and then washed 3 times with 0.1% PBST for 30 minutes. The secondary antibodies used were: Donkey anti-rabbit IgG-HRP (31458, Thermo Fisher) at 1:7500; and goat anti-mouse IgG-HRP (ab6789, Abcam) at 1:7500. The densitometry analysis of the blots was done using the Image Studio software (LI-COR Biotechnology). Cleaved caspase-3 and phospho-JNK blots were normalized to the GAPDH.
Confocal Microscopy. For confocal imaging, 150 μL of 150,000 cells were used in an 8-chamber slide (BD Falcon). After various incubation time, the cells were fixed with 4% (w/v) PFA overnight in 4 °C. The samples were then washed three times with PBS and then permeabilized with 0.05% (w/v) Triton X-100. After washing three more times with PBS, the cells were blocked with 5% BSA solution for 1 hour. The samples were then incubated in primary antibodies for 2 hours followed by 3 washes with PBS. The antibodies used are: anti-phospho-SAPK/ JNK (Thr183/Tyr185) (81E11, Cell Signaling) rabbit antibody at 1:1000; anti-myeloperoxidase mouse antibody (ab25989, Abcam) at 1:1000; and anti-cleaved caspase-3 rabbit antibody (Asp175, Cell Signaling) at 1:1000 were used to stain p-JNK, MPO and cleaved caspase-3, respectively. The samples were then treated with the secondary antibodies and nucleic acid-binding DAPI dye (Invitrogen) at 1:100 for 2 hours. The secondary antibodies used were: Donkey anti-mouse (488 nm, ab98766, Abcam) at 1:1000; and goat anti-rabbit (Alexa Fluor 555, A21428, life technologies) at 1:1000. The images were then taken using an Olympus IX81 inverted fluorescence microscope with a Hamamatsu C9100-13 back-thinned EM-CCD camera and Yokogawa CSU × 1 spinning disk confocal scan head with Spectral Aurora Borealis upgrade, 4 separate diode-pumped solid state laser lines (Spectral Applied Research, 405 nm, 491 nm, 561 nm, and 642 nm). The images were taken at 40 ×/0.95 magnification and then analyzed with Volocity Software (Perkin-Elmer).
Statistical Analysis. All the statistical analyses were performed on GraphPad Prism 7. One-Way ANOVA with Dunnett and Tukey's post tests, Two-way ANOVA with Bonferroni post-test or t-test was done as appropriate. A p-value of <0.05 was considered to represent significant differences between conditions and all data are presented as mean ± SEM.
